Recherchemedicale.com
Composés chimiques organiques
Composés organiques du phosphore
Phosphonates
Fosfomycine
Fosfomycine : Questions médicales fréquentes
Diagnostic
5
Infection urinaire
Analyse d'urine
Sensibilité aux antibiotiques
Tests de laboratoire
Symptômes
Infection urinaire
Bactéries gram-négatives
Bactéries gram-positives
Efficacité du traitement
Analyse d'urine
Symptômes
5
Symptômes
Infection urinaire
Effets secondaires
Réactions allergiques
Infection récurrente
Symptômes
Prévention
5
Prévention
Infection urinaire
Probiotiques
Flore urinaire
Vêtements
Infection urinaire
Hygiène
Infection urinaire
Traitements
5
Administration orale
Fosfomycine
Antibiotiques
Nitrofurantoïne
Résistance bactérienne
Fosfomycine
Complications
5
Complications
Infection rénale
Fosfomycine
Complications
Grossesse
Infection urinaire
Infection rénale
Symptômes
Infections récurrentes
Complications
Facteurs de risque
5
Facteurs de risque
Infection urinaire
Femmes
Infection urinaire
Maladies chroniques
Facteurs de risque
Cathéters
Infection urinaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fosfomycine : Questions médicales les plus fréquentes",
"headline": "Fosfomycine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fosfomycine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-05",
"dateModified": "2024-11-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fosfomycine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phosphonates",
"url": "https://recherchemedicale.com/mesh/D063065",
"about": {
"@type": "MedicalCondition",
"name": "Phosphonates",
"code": {
"@type": "MedicalCode",
"code": "D063065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.705.429"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fosfomycine",
"alternateName": "Fosfomycin",
"code": {
"@type": "MedicalCode",
"code": "D005578",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yanyan Liu",
"url": "https://recherchemedicale.com/author/Yanyan%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Jiabin Li",
"url": "https://recherchemedicale.com/author/Jiabin%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Xiaohui Huang",
"url": "https://recherchemedicale.com/author/Xiaohui%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Fernando Docobo-Pérez",
"url": "https://recherchemedicale.com/author/Fernando%20Docobo-P%C3%A9rez",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain."
}
},
{
"@type": "Person",
"name": "Yaowen Li",
"url": "https://recherchemedicale.com/author/Yaowen%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Resensitization of Fosfomycin-Resistant",
"datePublished": "2022-08-16",
"url": "https://recherchemedicale.com/article/36012441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23169175"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fosfomycin resistance mechanisms in",
"datePublished": "2023-07-04",
"url": "https://recherchemedicale.com/article/37469601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2023.1178547"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.",
"datePublished": "2024-05-28",
"url": "https://recherchemedicale.com/article/38806739",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00345-024-05048-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Collateral Sensitivity to Fosfomycin of Tobramycin-Resistant Mutants of",
"datePublished": "2023-04-07",
"url": "https://recherchemedicale.com/article/37108055",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24086892"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in",
"datePublished": "2022-08-11",
"url": "https://recherchemedicale.com/article/35951075",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/mdr.2021.0410"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://recherchemedicale.com/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés organiques du phosphore",
"item": "https://recherchemedicale.com/mesh/D009943"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phosphonates",
"item": "https://recherchemedicale.com/mesh/D063065"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fosfomycine",
"item": "https://recherchemedicale.com/mesh/D005578"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fosfomycine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fosfomycine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-31",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fosfomycine",
"description": "Comment diagnostiquer une infection urinaire ?\nQuels tests sont utilisés pour la fosfomycine ?\nQuels symptômes indiquent une infection nécessitant la fosfomycine ?\nLa fosfomycine est-elle efficace contre toutes les bactéries ?\nComment évaluer l'efficacité de la fosfomycine ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fosfomycine",
"description": "Quels sont les symptômes d'une infection traitée par fosfomycine ?\nLa fosfomycine provoque-t-elle des effets secondaires ?\nComment reconnaître une infection récurrente ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes indiquent une complication d'infection ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fosfomycine",
"description": "Comment prévenir les infections urinaires ?\nLes probiotiques aident-ils à prévenir les infections ?\nLe port de vêtements serrés influence-t-il les infections ?\nL'hydratation joue-t-elle un rôle dans la prévention ?\nLes douches sont-elles meilleures que les bains pour prévenir les infections ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fosfomycine",
"description": "Comment la fosfomycine est-elle administrée ?\nQuelle est la posologie standard de fosfomycine ?\nLa fosfomycine est-elle utilisée en pédiatrie ?\nQuels antibiotiques sont alternatifs à la fosfomycine ?\nLa fosfomycine est-elle efficace contre les résistances bactériennes ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fosfomycine",
"description": "Quelles sont les complications possibles d'une infection urinaire ?\nComment la fosfomycine aide-t-elle à éviter les complications ?\nLes infections urinaires peuvent-elles causer des problèmes de grossesse ?\nQuels signes indiquent une infection rénale ?\nLes infections urinaires récurrentes augmentent-elles les risques ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fosfomycine",
"description": "Quels sont les facteurs de risque d'infections urinaires ?\nLes femmes sont-elles plus à risque que les hommes ?\nL'âge influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nL'utilisation de cathéters est-elle un facteur de risque ?",
"url": "https://recherchemedicale.com/mesh/D005578#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection urinaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par analyse d'urine et culture pour identifier les bactéries."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la fosfomycine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont réalisés pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection nécessitant la fosfomycine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur lors de la miction, besoin fréquent d'uriner et fièvre."
}
},
{
"@type": "Question",
"name": "La fosfomycine est-elle efficace contre toutes les bactéries ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement efficace contre certaines bactéries gram-négatives et gram-positives."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la fosfomycine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes et des résultats d'analyse d'urine."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection traitée par fosfomycine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, brûlure à la miction, et urine trouble ou malodorante."
}
},
{
"@type": "Question",
"name": "La fosfomycine provoque-t-elle des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires peuvent inclure diarrhée, nausées et réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection récurrente ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection récurrente se manifeste par des symptômes similaires dans un court laps de temps."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées, comme la confusion."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication d'infection ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme fièvre élevée, douleurs abdominales ou vomissements peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections urinaires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire beaucoup d'eau, uriner après les rapports sexuels et maintenir une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Les probiotiques aident-ils à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains probiotiques peuvent aider à maintenir une flore urinaire saine."
}
},
{
"@type": "Question",
"name": "Le port de vêtements serrés influence-t-il les infections ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vêtements serrés peuvent favoriser la chaleur et l'humidité, augmentant le risque."
}
},
{
"@type": "Question",
"name": "L'hydratation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à éliminer les bactéries du système urinaire."
}
},
{
"@type": "Question",
"name": "Les douches sont-elles meilleures que les bains pour prévenir les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douches sont souvent recommandées pour éviter la prolifération bactérienne."
}
},
{
"@type": "Question",
"name": "Comment la fosfomycine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie orale sous forme de poudre dissoute dans l'eau."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de fosfomycine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est souvent de 3 grammes en dose unique pour les infections urinaires."
}
},
{
"@type": "Question",
"name": "La fosfomycine est-elle utilisée en pédiatrie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être utilisée chez les enfants, mais la posologie doit être ajustée."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont alternatifs à la fosfomycine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives incluent la nitrofurantoïne et les fluoroquinolones selon la sensibilité."
}
},
{
"@type": "Question",
"name": "La fosfomycine est-elle efficace contre les résistances bactériennes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent efficace contre des souches résistantes, mais pas contre toutes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection urinaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections rénales, des septicémies et des dommages rénaux."
}
},
{
"@type": "Question",
"name": "Comment la fosfomycine aide-t-elle à éviter les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle traite rapidement les infections urinaires, réduisant le risque de complications graves."
}
},
{
"@type": "Question",
"name": "Les infections urinaires peuvent-elles causer des problèmes de grossesse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des complications comme le travail prématuré ou des infections néonatales."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection rénale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des douleurs lombaires, fièvre élevée et nausées."
}
},
{
"@type": "Question",
"name": "Les infections urinaires récurrentes augmentent-elles les risques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent augmenter le risque de complications à long terme, comme des lésions rénales."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infections urinaires ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'anatomie, les antécédents d'infections et l'utilisation de certains contraceptifs."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque que les hommes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur anatomie, les femmes sont plus susceptibles de développer des infections urinaires."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison de changements dans le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent affaiblir le système immunitaire et augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'utilisation de cathéters est-elle un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de cathéters augmente le risque d'infections urinaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/11/2024
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
4 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
4 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
4 publications dans cette catégorie
Affiliations :
Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Departamento de Microbiología, Universidad de Sevilla, 41013 Seville, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Department of Basic and Clinical Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, People's Republic of China.
Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, People's Republic of China.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Programa de Doctorado en Biociencias Moleculares, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Centro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Graduate Program in Veterinary Bioscience, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Center of Excellence for Food and Water Risk Analysis (FAWRA), Department of Veterinary Public Health, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
Department of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Departamento de Microbiología, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.
Instituto de Biomedicina de Sevilla IBIS, Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41009 Sevilla, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Instituto de Biomedicina de Sevilla IBIS, Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41009 Sevilla, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.
Instituto de Biomedicina de Sevilla IBIS, Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, 41009 Sevilla, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Centro Nacional de Biotecnología, CSIC, 28043 Madrid, Spain.
Publications dans "Fosfomycine" :
3 publications dans cette catégorie
Affiliations :
Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland patrice.nordmann@unifr.ch.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (LEA, IAME), University of Fribourg, Fribourg, Switzerland.
University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Publications dans "Fosfomycine" :
Antimicrobial resistance is a public health burden with worldwide impacts and was recently identified as one of the major causes of death in 2019. Fosfomycin is an antibiotic commonly used to treat ur...
Antimicrobial resistance is well-known to be a global health and development threat. Due to the decrease of effective antimicrobials, re-evaluation in clinical practice of old antibiotics, as fosfomyc...
To evaluate antibiotic prophylaxis in transrectal prostate biopsies due to the recommendation of the European Medicines Agency (EMA): We describe our single center experience switching from ciprofloxa...
Between 01/2019 and 12/2020 we compared three different regimes. The primary endpoint was the clinical diagnosis of an infection within 4 weeks after biopsy. We enrolled 822 men, 398 (48%) of whom rec...
Baseline characteristics were similar between groups. In total 37/398 (5%) postinterventional infections were detected, of which 13/398 (3%) vs 18/136 (13.2%) vs 6/288 (2.1%) were detected in group-C,...
The replacement of ciprofloxacin by fosfomycin alone resulted in a significant increase of postinterventional infections, while the combination of FMT and TMP/SMX had a comparable infection rate to FQ...
Understanding the consequences in bacterial physiology of the acquisition of drug resistance is needed to identify and exploit the weaknesses derived from it. One of them is collateral sensitivity, a ...
The lack of internationally approved breakpoint and a handy susceptibility testing reduces fosfomycin usefulness against...
The intravenous form of fosfomycin, a bactericide antibiotic used to treat multiresistant bacterial infections is little prescribed. The most common reported adverse effects are hypokaliemia and hyper...
A 45 year-old woman was admitted to the intensive care unit for post-surgical meningitis following meningioma resection. Meropenem and vancomycin were first introduced. A DRESS-syndrom with meropenem ...
This is the third paper reporting agranulocytosis induced by fosfomycin, and the first detailed description of a case. Based on chronological and semiological criteria and bibliographic data, the even...
The aim of the study was to evaluate clinical and microbiological efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant...
Fosfomycin (FOS) has been recently reintroduced into clinical practice, but its effectiveness against multidrug-resistant (MDR)...
For treatment of ventriculitis, vancomycin and meropenem are frequently used as empiric treatment but cerebrospinal fluid (CSF) penetration is highly variable and may result in subtherapeutic concentr...
Adult patients receiving a continuous infusion of fosfomycin (1 g/h) for the treatment of ventriculitis were included. Routine therapeutic drug monitoring (TDM) of fosfomycin in serum and CSF was perf...
Seventeen patients with 43 CSF/serum pairs were included. Median fosfomycin serum concentration was 200 [159-289] mg/L and the CSF concentration 99 [66-144] mg/L. Considering only the first measuremen...
Penetration of fosfomycin into the CSF is high, reliably leading to appropriate concentrations for the treatment of gram positive and negative bacteria. Moreover, continuous administration of fosfomyc...
Fosfomycin, originally named phosphonomycin when it was first isolated from fermentation broth of Streptomyces species and synthesized at Merck in 1969. The phosphonic acid containing a structurally s...